Shakil A. Saghir

Shakil A. Saghir

Auto-generated profile, based on publicly available information

Shakil A. Saghir

Toxicology and Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Midland, MI 48674, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
SSShakil A. Saghir
Shakil A. Saghir
AMAlan L. Mendrala
Alan L. Mendrala
MBMichael J. Bartels
Michael J. Bartels
SDSue J. Day
Sue J. Day
SHSteve C. Hansen
Steve C. Hansen
JBJames S. Bus
James S. Bus

1 July 2012 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
SSShakil A. Saghir
Shakil A. Saghir
MBMichael J. Bartels
Michael J. Bartels
DRDavid L. Rick
David L. Rick
AMAlene T. McCoy
Alene T. McCoy
RRReza J. Rasoulpour
Reza J. Rasoulpour
JBJames S. Bus
James S. Bus

6 June 2008 in Toxicology Letters
Verified
Journal Article
Closed access
SSShakil A. Saghir
Shakil A. Saghir
GCGrantley D. Charles
Grantley D. Charles
MBMichael J. Bartels
Michael J. Bartels
LKLynn H.L. Kan
Lynn H.L. Kan
MDMark D. Dryzga
Mark D. Dryzga
ACAmy J. Clark
Amy J. Clark

15 December 2008 in Toxicological Sciences
Verified
Journal Article
Closed access
SSShakil A. Saghir
Shakil A. Saghir
DRDavid L. Rick
David L. Rick
EME. L. McClymont
E. L. McClymont
FZFagen Zhang
Fagen Zhang
MBMichael J. Bartels
Michael J. Bartels
JBJames S. Bus
James S. Bus
This study was conducted to determine species differences in the metabolism of ethylbenzene (EB) in liver and lung. EB (0.22-7.0mM) was incubated with mouse, rat and human liver and lung microsomes and the formation of 1-phenylethanol (1PE), acetophenone (AcPh), 2-ethylphenol (2EP), 4-ethylphenol (4EP), 2,5-ethylquinone, and 3,4-ethylquinone were measured. Reactive metabolites (2,5-dihydroxyethylbenzene-GSH [2EP-GSH] and 3,4-dihydroxyethylbenzene-GSH [4EP-GSH]) were monitored via glutathione (GSH) trapping technique. None of the metabolites were formed at detectable levels in incubations with human lung microsomes. Percent conversion of EB to 1PE ranged from 1% (rat lung; 7.0mM EB) to 58% (mouse lung; 0.22 mM EB). More 1PE was formed in mouse lung than in mouse liver microsomes, although formation of 1PE by rat liver and lung microsomes was similar. Metabolism of EB to 1PE was in the order of mouse > rat > human. Formation of AcPh was roughly an order of magnitude lower than 1PE. Conversion of EB to ring-hydroxylated metabolites was much lower (0.0001% [4EP-GSH; rat lung] to 0.6% [2EP-GSH; mouse lung]); 2EP-GSH was typically 10-fold higher than 4EP-GSH. Formation of 2EP-GSH was higher by lung (highest by mouse lung) than liver microsomes and the formation of 2EP-GSH by mouse liver microsomes was higher than rat and human liver microsomes. Increasing concentrations of EB did lead to a decrease in amount of some formed metabolites. This may indicate some level of substrate- or metabolite-mediated inhibition. High concentrations of 2EP and 4EP were incubated with microsomes to further investigate their oxidation to ethylcatechol (ECat) and ethylhydroquinone (EHQ). Conversion of 2EP to EHQ ranged from 6% to 9% by liver (mouse > human > rat) and from 0.1% to 18% by lung microsomes (mouse >> rat >> human). Conversion of 4EP to ECat ranged from 2% to 4% by liver (mouse > human approximately rat) and from 0.3% to 7% by lung microsomes (mouse >> rat >> human). Although ring-oxidized metabolites accounted for a relatively small fraction of overall EB metabolism, its selective elevation in mouse lung microsomes is nonetheless consistent with the hypothesized mode of action for observed preferential toxicity of EB to the lung in this species.

1 July 2010 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
SSShakil A. Saghir
Shakil A. Saghir
FZFagen Zhang
Fagen Zhang
DRDavid L. Rick
David L. Rick
LKLynn Kan
Lynn Kan
JBJames S. Bus
James S. Bus
MBMichael J. Bartels
Michael J. Bartels

6 May 2010 in International Journal of Toxicology
Verified
Journal Article
Closed access
PDF file
SSShakil A. Saghir
Shakil A. Saghir
MBMichael J. Bartels
Michael J. Bartels
WSWilliam M. Snellings
William M. Snellings
This study was conducted to determine the in vitro dermal absorption of ethylene glycol (EG) through dermatomed human abdominal skin (containing epidermis and dermis), obtained from cadavers within 24 hours of death and kept frozen until processed. Three formulations of EG (neat, 50%, and 10% aqueous solutions) were applied in triplicate to skin samples from 6 donors, and placed in Teflon Bronaugh flow-through diffusion cells. Barrier integrity of each sample was evaluated with 3H-H2O prior to applying EG and only data from samples passing the test were used. A physiological receptor fluid was pumped beneath the skin samples and collected in a fraction collector at predetermined time points through 24 hours. Possible volatilized EG was trapped in a charcoal basket located above each skin sample. Each skin sample was treated with an infinite dose of 500 µL of EG formulation/cm2. At the end of 24 hours, volatilized EG trapped in the headspace was collected, the unabsorbed dose was removed from the skin and the skin was rinsed, tape stripped, and solubilized along with a rinse of the flow-through cells, and total radioactivity was determined. Only a small fraction (≤1%) of the applied EG was absorbed in 24 hours, of which <0.7% penetrated through the skin and ~0.4% remained in the skin. Recovery (mass balance) of the applied EG was between 93% and 99%, which further validated the observed low dermal penetration of EG. The net penetration of the applied EG over 24 hours was concentration proportional, comprising 2.97 ± 0.78, 1.75 ± 0.62, and 0.23 ± 0.12 mg/cm2 of the neat, 50%, and 10% formulations, respectively. The steady-state flux of EG was established between 16 and 24 hours. The mean steady-state flux of EG through dermatomed skin was 217, 129, and 15 µg/cm2h for the neat, 50%, and 10% aqueous formulations, respectively, consistent with concentration-proportional penetration of EG. The steady-state permeation coefficient (Kp) for EG was low, between 1.5 × 10−4 and 2.6 × 10−4 cm/h. These findings demonstrate that EG dermal penetration is expected to be very low and to be slow, indicating very limited systemic or internal dose of EG due to dermal exposure.